Substance
COBICISTAT
Global reference: every product and company linked to this substance.
- cas: 1004316-88-4
- ncit: C97360
- pubchem_cid: 25151504
- rxnorm: 1306284
- unii: LW2E03M5PG
cobicistat [INN] · COBICISTAT [JAN] · COBICISTAT [USAN] · Cobicistat [WHO-DD] · EVOTAZ COMPONENT COBICISTAT · GENVOYA COMPONENT COBICISTAT · GS-9350 · PREZCOBIX COMPONENT COBICISTAT · PREZCOBIX PED COMPONENT COBICISTAT · REZOLSTA COMPONENT COBICISTAT · STRIBILD COMPONENT COBICISTAT · SYMTUZA COMPONENT COBICISTAT
Revenue by product (4)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | PREZCOBIX | Q2 2026 | $372.0M* |
| JOHNSON & JOHNSON COMMON STOCK | SYMTUZA | Q2 2026 | $372.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | GENVOYA | Q2 2026 | $289.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | STRIBILD | Q4 2023 | $22.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (8)
- COBICISTAT · VIATRIS INC. COMMON STOCK
- EVOTAZ · BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
- GENVOYA · GILEAD SCIENCES INC. COMMON STOCK
- PREZCOBIX · JOHNSON & JOHNSON COMMON STOCK
- PREZCOBIX PED · JOHNSON & JOHNSON COMMON STOCK
- STRIBILD · GILEAD SCIENCES INC. COMMON STOCK
- SYMTUZA · JOHNSON & JOHNSON COMMON STOCK
- TYBOST · GILEAD SCIENCES INC. COMMON STOCK